Also known as Lotronex
Alosetron hydrochloride (initial brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego), also under the trade name Lotronex. Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.Source: Wikipedia
Estimated Total Cost: $790.2 for an average of 28 days supply
Patients are most commonly prescribed alosetron to treat blastomycosis, rabies, west nile virus, and pick disease.
Patients taking alosetron most commonly experience side effects like constipation, nausea, and abdominal pain.